- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Cerecor is a biotechnology business based in the US. Cerecor shares (CERC) are listed on the NASDAQ and all prices are listed in US Dollars. Cerecor employs 30 staff and has a trailing 12-month revenue of around $6.4 million.
Our top picks for where to buy Cerecor stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Cerecor stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CERC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cerecor stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cerecor stock price (NASDAQ: CERC)
Use our graph to track the performance of CERC stocks over time.Cerecor shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $2.88 |
200-day moving average | $3.01 |
Wall St. target price | $6.50 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.87 |
Is it a good time to buy Cerecor stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
N/ACerecor financials
Revenue TTM | $6.4 million |
---|---|
Gross profit TTM | $-18,536,584 |
Return on assets TTM | -72.52% |
Return on equity TTM | -213.81% |
Profit margin | 0% |
Book value | $0.23 |
Market Capitalization | $285 million |
TTM: trailing 12 months
Cerecor share dividends
We're not expecting Cerecor to pay a dividend over the next 12 months.
Cerecor share price volatility
Over the last 12 months, Cerecor's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cerecor's is 1.4406. This would suggest that Cerecor's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cerecor overview
Cerecor Inc. , a biopharmaceutical company, focuses on development and commercialization of treatments for rare and orphan diseases. The company develops monosaccharide therapies for the treatment of congenital disorders of glycosylation, such as CERC-801, CERC-802, and CERC-803. It is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of adult onset stills disease and multiple myeloma, as well as for the treatment of systemic juvenile idiopathic arthritis; CERC-006, an oral mTORC1/2 inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody that is in phase 2 clinical trial for the treatment of COVID-19 acute respiratory distress syndrome, as well as for the treatment of pediatric-onset Crohn's diseases. In addition, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. Cerecor Inc. has a collaboration agreement with The Frontiers in Congenital Disorders of Glycosylation Consortium on pivotal trial of CERC-801 for the treatment of Phosphoglucomutase-1 deficiency related congenital disorders of glycosylation.
Frequently asked questions
nullWhat percentage of Cerecor is owned by insiders or institutions?
Currently 0.79% of Cerecor shares are held by insiders and 70.39% by institutions. How many people work for Cerecor?
Latest data suggests 30 work at Cerecor. When does the fiscal year end for Cerecor?
Cerecor's fiscal year ends in December. Where is Cerecor based?
Cerecor's address is: 540 Gaither Road, Rockville, MD, United States, 20850 What is Cerecor's ISIN number?
Cerecor's international securities identification number is: US05338F1084 What is Cerecor's CUSIP number?
Cerecor's Committee on Uniform Securities Identification Procedures number is: 15671L208
More guides on Finder
-
How to Trade Options on SoFi®: A Beginner’s Guide
Step 1: Open and fund your account, Step 2: Enable options trading, Step 3: Select and trade options, Step 4: Closing options trades.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Call options explained
Learn the basics of call options: what they are, how they work and examples.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Zacks Trade review 2024
What to expect when you sign up for a Zacks Trade brokerage account.
Ask a question